Avivagen Inc., pursuant to the requirements of the TSX Venture Exchange, has granted options to purchase 8,487,763 common shares to its executive team, including the newly announced president and chief executive officer, employees, members of its board ...
[Published Stockwatch - Mar 12 2013]